Application of thrombolytic drugs on clotted blood and bone marrow specimens to generate usable cells for cytogenetic analyses

Archives of Pathology and Laboratory Medicine

Volumn 135, Issue 7, 2011, Pages 915-919

  St Antoine, Angelique ^a   Ketterling, Morgan N ^a   Sukov, William R ^a   Lowman, Josh ^a   Knudson, Ryan A ^a   Sinnwell, Jason P ^a   Wiktor, Anne E ^a   Ketterling, Rhett P ^a  

^a MAYO CLINIC   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

FIBRINOLYTIC AGENT;

ARTICLE; BLOOD CLOTTING; CHROMOSOME ANALYSIS; HUMAN; METHODOLOGY;

BLOOD COAGULATION; CYTOGENETIC ANALYSIS; FIBRINOLYTIC AGENTS; HUMANS;

EID: 79960806557     PISSN: 00039985     EISSN: 15432165     Source Type: Journal    
DOI: None     Document Type: Article

References (5)

1. Meretoja A, Tathsumak T. Thrombolytic therapy in acute ischemic stroke- basic concepts. Curr Vase Pharmacol. 2006;4(1):31-44. (Pubitemid 46785180)
2. Tanswell P, Tebbe U, Neuhaus KL, Glasle-Schwarz L, Wojcik J, Seifried E. Pharmacokinetics and fibrin specificity of alteplase during accelerated infusions in acute myocardial infarction. J Am Coll Cardiol. 1992;19(5):1071-1075.
3. Brown MG, Lawce HJ. Peripheral blood cytogenetics methods. In: Barch M, Knutsen T, Spurbeck J, eds. AGT Cytogenetics Laboratory Manual. 3rd ed. Philadelphia, PA: Lippincott-Raven; 1997:77-87.
4. Niku SD, Hoon DS, Cochran AJ, Morton DL. Isolation of lymphocytes from clotted blood, J Immunol Methods. 1987;105(1):9-14. (Pubitemid 17163131)
5. De Vis J, Renmans W, Segers E, Jochmans K, De Waele M. Flow cytometric immunophenotyping of leukemia cells in clotted blood and bone marrow. J Immunol Methods. 1991;137(2):193-197.